CSIMarket Company Name, Ticker, Competitors, else..
Goodrx Holdings Inc   (NASDAQ: GDRX)
Other Ticker:  
 


 

Goodrx Holdings Inc

GDRX's Financial Statements and Analysis



Goodrx Holdings Inc reported break-even for the third quarter of 2025 compare to earnings per share of $0.02 recorded in the same quarter a year ago a decrease from $0.03 realized in I. Quarter (Mar 31 2025).


third quarter of 2025
Earnings Per Share Revenues
$ 0 $  196 Mill
$-0.02     $-5M     -2.28 %



Goodrx Holdings Inc 's Revenue fell by -2.28 % in third quarter of 2025 (Sep 30 2025) year on year, to $196 million and declined by -3.42 % sequentially.


Goodrx Holdings Inc is

More on GDRX's Income Statement



Goodrx Holdings Inc 's net income of $1.119 million in the third quarter of 2025 decreased by -83.28 % from net earnings of $6.694 million achieved in II. Quarter a year ago.

Sequentially net earnings fell by -89.88 % from net income of $11.052 million realized in previous quarter.

More on GDRX's Growth

Goodrx Holdings Inc Inventories
In Sep 30 2025 company's net cash and cash equivalents decreased by $-27 million, capital expenditures fell by -17.229110.77%, to $-36 millions compare to same quarter a year ago

More on GDRX's Cash flow Statement


Goodrx Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period Goodrx Holdings Inc earned $ 0.77 cash per share, on a free-cash flow basis 1277.62 % of net earning per share.

Book value grew by 0.21 % sequentially to $1.73 per share, -22.43% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ 0.33 per share from $ 0.43.

Company repurchased 31.85 million shares or 8.39 % in Sep 30 2025.


• More on GDRX's Dividends

 Market Capitalization (Millions) 1,033
 Shares Outstanding (Millions) 348
 Total Debt (Millions $) 489
 Revenue (TTM) (Millions $) 793
 Net Income (TTM) (Millions $) 23
 Cash Flow (TTM) (Millions $) -251
 Capital Exp. (TTM) (Millions $) -91
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 694




Goodrx Holdings Inc does not pay out common stock dividend.

In trailing twelve-month period Goodrx Holdings Inc had $ 0.77 cash flow per share, on a free-cash flow basis 1277.62 % of net earning per share.

Book value grew by 0.21 % sequentially to $1.73 per share, -22.43% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ 0.33 per share from $ 0.43.

Company repurchased 31.85 million shares or 8.39 % in Sep 30 2025.


• More on GDRX's Balance Sheets

 Market Capitalization (Millions) 1,033
 Shares Outstanding (Millions) 348
 Total Debt (Millions $) 489
 Revenue (TTM) (Millions $) 793
 Net Income (TTM) (Millions $) 23
 Cash Flow (TTM) (Millions $) -251
 Capital Exp. (TTM) (Millions $) -91
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 694
   


  News about Goodrx Holdings Inc Earnings

1 GoodRx Holdings Inc Reports $1.30 Million Tax Charge Amid Bearish Financial Performance

GoodRx Holdings Inc (GDRX) has been on a rollercoaster ride in the financial markets recently, but unfortunately for investors, the ride seems to be headed in a bearish direction. Despite reaching a zero gain per share in the financial time-frame closing March 31 2024, it is important to note that this is not necessarily a positive sign for the company. As compared to a net loss of $-0.01 per share the year before, and even worse at $-0.06 per share in the preceding reporting season, it is clear that GoodRx Holdings Inc has been struggling to generate profits for its investors.
While the revenue did show a slight improvement of 7.552% to $197.88 million from the previous year, this growth is not enough t...

GoodRx Holdings Inc. Faces Loss Despite Revenue Growth in Q4 2023

GoodRx Holdings Inc. is a company that has been focused on making healthcare more affordable and accessible for people across the United States. Recently, their stock experienced a drop of 4.08% in February 2024, bringing the share price down by 21.99% in the past 90 days. Despite this drop, the stock is still trading on the NASDAQ at a value that is 7% above its 52-week average.
Looking at the company's financials, it is evident that GoodRx Holdings Inc. has been experiencing diminishing returns. In the fiscal period ending December 31, 2023, the company's earnings per share (EPS) expanded to $-0.06 per share, compared to $0.00 per share the previous year. Additionally, the EPS improved from $-0.09 per ...

Goodrx Holdings Inc Reports Third Quarter of 2023 with Per Share Shortfall of -$0.09, Highlighting Financial Struggles Ahead

GoodRx Holdings Inc, a leading provider of prescription drug pricing information and healthcare services, experienced a loss in the third quarter of 2023. The company reported a loss of $-0.09 per share, compared to a loss of $-0.10 per share in the same quarter the previous year. Additionally, the income per share fell from $0.14 per share in the preceding quarter.
The revenue for the third quarter contracted by -3.929% to $179.96 million, down from $187.32 million in the corresponding quarter of the previous year. Sequentially, the revenue decreased by -5.124% from $189.68 million. This decline in revenue is in contrast to the overall trend in the Cloud Computing and Data Analytics sector, which saw a ...

Goodrx Holdings Inc Reports Fiscal Q2 Results: Earnings Soar by $46.72 Million due to Income Tax Provisions

Goodrx Holdings Inc, a leading name in the Cloud Computing and Data Analytics sector, recently announced its fiscal second-quarter results for 2023. While the company experienced a modest revenue contraction, its earnings per share remained unchanged at $0.14. The revenue depreciated by -1.106% to $189.68 million compared to the previous year.
However, Goodrx Holdings Inc's performance in the second quarter of 2023 was in contrast to the rest of the sector. The overall sector recorded a revenue improvement of 1.70% relative to the corresponding period a year ago. Despite this, Goodrx Holdings Inc managed to turn its earnings per share positive from the previous quarter, which was at $-0.01 per share.

Struggling Goodrx Holdings Inc Faces Steep Revenue Decline, Threatening its Financial Stability in First Quarter 2023

Goodrx Holdings Inc is a popular American company that provides an online platform for comparing drug prices and obtaining discounts through various healthcare plans. As a technology-based company, Goodrx is known for its innovative solutions that help its customers save money on prescription drugs. However, the company has been experiencing difficult times financially, as reflected in its recent financial statements.
Goodrx Holdings Inc recorded a cumulative net loss of $-48 million during the twelve months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -3.04%. This is a significant setback ...


Date modified: 2025-11-05T06:30:16+00:00




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.